Literature DB >> 23444405

Erk1 and Erk2 are required for maintenance of hematopoietic stem cells and adult hematopoiesis.

Gordon Chan1, Shengqing Gu, Benjamin G Neel.   

Abstract

Extracellular signal-regulated kinase 1 (Erk1) and Erk2 play crucial roles in cell survival, proliferation, cell adhesion, migration, and differentiation in many tissues. Here, we report that the absence of Erk1 and Erk2 in murine hematopoietic cells leads to bone marrow aplasia, leukopenia, anemia, and early lethality. Mice doubly-deficient in Erk1 and Erk2 show rapid attrition of hematopoietic stem cells and immature progenitors in a cell-autonomous manner. Reconstitution studies show that Erk1 and Erk2 play redundant and kinase-dependent functions in hematopoietic progenitor cells. Moreover, in cells transformed by the oncogenic KRas(G12D) allele, the presence of either Erk1 or Erk2 with intact kinase activity is sufficient to promote cytokine-independent proliferation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23444405      PMCID: PMC3643760          DOI: 10.1182/blood-2012-12-476200

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  20 in total

Review 1.  Src family kinases and the MEK/ERK pathway in the regulation of myeloid differentiation and myeloid leukemogenesis.

Authors:  Daniel E Johnson
Journal:  Adv Enzyme Regul       Date:  2007-11-19

Review 2.  MAPK signaling pathways in the regulation of hematopoiesis.

Authors:  Christian R Geest; Paul J Coffer
Journal:  J Leukoc Biol       Date:  2009-06-04       Impact factor: 4.962

3.  ERK2 but not ERK1 induces epithelial-to-mesenchymal transformation via DEF motif-dependent signaling events.

Authors:  Sejeong Shin; Christopher A Dimitri; Sang-Oh Yoon; William Dowdle; John Blenis
Journal:  Mol Cell       Date:  2010-04-09       Impact factor: 17.970

Review 4.  Role of Ras/Raf/MEK/ERK signaling in physiological hematopoiesis and leukemia development.

Authors:  Eva Chung; Motonari Kondo
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

5.  A MEK inhibitor abrogates myeloproliferative disease in Kras mutant mice.

Authors:  Natalya Lyubynska; Matthew F Gorman; Jennifer O Lauchle; Wan Xing Hong; Jon K Akutagawa; Kevin Shannon; Benjamin S Braun
Journal:  Sci Transl Med       Date:  2011-03-30       Impact factor: 17.956

6.  The role of erk1 and erk2 in multiple stages of T cell development.

Authors:  April M Fischer; Carol D Katayama; Giles Pagès; Jacques Pouysségur; Stephen M Hedrick
Journal:  Immunity       Date:  2005-10       Impact factor: 31.745

7.  Erk kinases link pre-B cell receptor signaling to transcriptional events required for early B cell expansion.

Authors:  Tomoharu Yasuda; Hideki Sanjo; Gilles Pagès; Yohei Kawano; Hajime Karasuyama; Jacques Pouysségur; Masato Ogata; Tomohiro Kurosaki
Journal:  Immunity       Date:  2008-03-20       Impact factor: 31.745

8.  The Erk2 MAPK regulates CD8 T cell proliferation and survival.

Authors:  Warren N D'Souza; Chiung-Fang Chang; April M Fischer; Manqing Li; Stephen M Hedrick
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

9.  Mutation of position 52 in ERK2 creates a nonproductive binding mode for adenosine 5'-triphosphate.

Authors:  M J Robinson; P C Harkins; J Zhang; R Baer; J W Haycock; M H Cobb; E J Goldsmith
Journal:  Biochemistry       Date:  1996-05-07       Impact factor: 3.162

10.  Essential role for ERK2 mitogen-activated protein kinase in placental development.

Authors:  Naoya Hatano; Yoshiko Mori; Masatsugu Oh-hora; Atsushi Kosugi; Takahiko Fujikawa; Naoya Nakai; Hitoshi Niwa; Jun-ichi Miyazaki; Toshiyuki Hamaoka; Masato Ogata
Journal:  Genes Cells       Date:  2003-11       Impact factor: 1.891

View more
  22 in total

1.  Musashi2 sustains the mixed-lineage leukemia-driven stem cell regulatory program.

Authors:  Sun-Mi Park; Mithat Gönen; Ly Vu; Gerard Minuesa; Patrick Tivnan; Trevor S Barlowe; James Taggart; Yuheng Lu; Raquel P Deering; Nir Hacohen; Maria E Figueroa; Elisabeth Paietta; Hugo F Fernandez; Martin S Tallman; Ari Melnick; Ross Levine; Christina Leslie; Christopher J Lengner; Michael G Kharas
Journal:  J Clin Invest       Date:  2015-02-09       Impact factor: 14.808

2.  Microfluidic Cell Trap Arrays for Single Hematopoietic Stem/Progenitor Cell Behavior Analysis.

Authors:  Xin Han; Yuan Ma; Kai Zhang; Pengchao Zhang; Ning Shao; Lidong Qin
Journal:  Proteomics       Date:  2020-01-03       Impact factor: 3.984

3.  The CD27+ memory B cells display changes in the gene expression pattern in elderly individuals.

Authors:  Alicia Báez; Isabel Alvarez-Laderas; José I Piruat; Teresa Caballero-Velázquez; M Victoria Barbado; Africa Millán-Uclés; Mayte Medrano; Estefanía García-Guerrero; Li Sánchez-Abarca; José Antonio Pérez-Simón
Journal:  Immunology       Date:  2014-09-06       Impact factor: 7.397

4.  Functional divergence caused by mutations in an energetic hotspot in ERK2.

Authors:  Clinton A Taylor; Kevin W Cormier; Shannon E Keenan; Svetlana Earnest; Steve Stippec; Chonlarat Wichaidit; Yu-Chi Juang; Junmei Wang; Stanislav Y Shvartsman; Elizabeth J Goldsmith; Melanie H Cobb
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-11       Impact factor: 11.205

5.  Targeting compensatory MEK/ERK activation increases JAK inhibitor efficacy in myeloproliferative neoplasms.

Authors:  Simona Stivala; Tamara Codilupi; Sime Brkic; Anne Baerenwaldt; Nilabh Ghosh; Hui Hao-Shen; Stephan Dirnhofer; Matthias S Dettmer; Cedric Simillion; Beat A Kaufmann; Sophia Chiu; Matthew Keller; Maria Kleppe; Morgane Hilpert; Andreas S Buser; Jakob R Passweg; Thomas Radimerski; Radek C Skoda; Ross L Levine; Sara C Meyer
Journal:  J Clin Invest       Date:  2019-03-04       Impact factor: 14.808

6.  Critical role of Jak2 in the maintenance and function of adult hematopoietic stem cells.

Authors:  Hajime Akada; Saeko Akada; Robert E Hutchison; Kazuhito Sakamoto; Kay-Uwe Wagner; Golam Mohi
Journal:  Stem Cells       Date:  2014-07       Impact factor: 6.277

7.  Immunodeficiency in a Patient with 22q11.2 Distal Deletion Syndrome and a p.Ala7dup Variant in the MAPK1 Gene.

Authors:  Ana I Sánchez; Mary A García-Acero; Angela Paredes; Rossi Quero; Rita I Ortega; Jorge A Rojas; Daniel Herrera; Miguel Parra; Karol Prieto; Juana Ángel; Luz-Stella Rodríguez; Juan C Prieto; Manuel Franco
Journal:  Mol Syndromol       Date:  2020-02-05

8.  Arginine methyltransferase PRMT5 is essential for sustaining normal adult hematopoiesis.

Authors:  Fan Liu; Guoyan Cheng; Pierre-Jacques Hamard; Sarah Greenblatt; Lan Wang; Na Man; Fabiana Perna; Haiming Xu; Madhavi Tadi; Luisa Luciani; Stephen D Nimer
Journal:  J Clin Invest       Date:  2015-08-10       Impact factor: 14.808

9.  An integrated global regulatory network of hematopoietic precursor cell self-renewal and differentiation.

Authors:  Yanan You; Raquel Cuevas-Diaz Duran; Lihua Jiang; Xiaomin Dong; Shan Zong; Michael Snyder; Jia Qian Wu
Journal:  Integr Biol (Camb)       Date:  2018-07-16       Impact factor: 2.192

10.  Thrombopoietin promotes NHEJ DNA repair in hematopoietic stem cells through specific activation of Erk and NF-κB pathways and their target, IEX-1.

Authors:  Bérengère de Laval; Patrycja Pawlikowska; Daniela Barbieri; Corinne Besnard-Guerin; Alba Cico; Rajiv Kumar; Murielle Gaudry; Véronique Baud; Françoise Porteu
Journal:  Blood       Date:  2013-11-01       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.